World News
Lilly reports second-quarter 2026 financial results, raises full-year guidance, and highlights continued growth and pipeline progress – Eli Lilly and Company
- Lilly reports second-quarter 2026 financial results, raises full-year guidance, and highlights continued growth and pipeline progress Eli Lilly and Company
- Eli Lilly Posts Higher Revenue on Continued GLP-1 Demand WSJ
- Eli Lilly raises annual revenue forecast as GLP-1 drugs fuel growth Reuters
- Eli Lilly and Novo Nordisk raise profit outlook as demand for weight-loss drugs soars Financial Times
- Here’s How Much Traders See Eli Lilly Stock Moving After Earnings Investopedia